Ensho Therapeutics, Inc. — Form D
Ensho Therapeutics, Inc. of Woodcliff Lake, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-12. The offering totals $12.5M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-11-12
- Form: D
- Accession: 0002032849-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.5M
- Amount sold: $5.0M
- Remaining: $7.5M
- Investors: 1
- Date of first sale: 2024-10-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-529131
Issuer
- Name: Ensho Therapeutics, Inc.
- CIK: 0002032849
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 50 Tice Boulevard, Woodcliff Lake, NJ, 07677
- Phone: 973-475-8970
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Danielle Andrew Fry | Executive Officer | Morris Plains, NJ |
| Matthew Andrew McKevitt | Executive Officer | Morris Plains, NJ |
| Emily Andrew Weng | Executive Officer | Morris Plains, NJ |
| James Andrew Whitney | Executive Officer | Morris Plains, NJ |
| Neena Bitritto-Garg | Director | Morris Plains, NJ |
| Neena Bitritto-Garg | Executive Officer | Morris Plains, NJ |
| Neena Bitritto-Garg | Promoter | Morris Plains, NJ |
| Emily Weng | Executive Officer | Morris Plains, NJ |
| Eric Pham | Director | Woodcliff Lake, NJ |
| Matthew McKevitt | Executive Officer | Morris Plains, NJ |
| Arash Rassoulpour | Director | Woodcliff Lake, NJ |
| Carlos Solorzano | Director | Woodcliff Lake, NJ |
| James Whitney | Executive Officer | Morris Plains, NJ |
| Danielle Fry | Executive Officer | Woodcliff Lake, NJ |
| Bittoo Kanwar | Executive Officer | Morris Plains, NJ |
| Gerhard Hagn | Executive Officer | Woodcliff Lake, NJ |
Other filings by this issuer (3)
More